5AM PARTNERS VII, LLC sold 80.1% of their position (266.34K shares) of SKYE BIOSCIENCE, INC. on the open market
Open‑market sale worth $1.75M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 6 sales
Filed: 9/13/2024ACC: 0001415889-24-023399
10% Owner
Since Aug 2023
-266.34K
Net shares
Net seller
$1.75M
Total sold
6
Open market trades
0B · 6S
6
Total transactions
266.34K disposed
Non-Derivative Transactions6
Common Stock
Indirect
Shares
−214.56K
Price / share
$6.60
Trade value
$1.42M
% of position
2.6%
9/11/2024
8.39M→8.18M
Common Stock
Indirect
Shares
−36.50K
Price / share
$6.60
Trade value
$240.93K
% of position
2.1%
9/11/2024
1.72M→1.68M
Common Stock
Indirect
Shares
−1.44K
Price / share
$6.60
Trade value
$9.50K
% of position
2.1%
9/11/2024
67.80K→66.36K
Common Stock
Indirect
Shares
−11.76K
Price / share
$6.06
Trade value
$71.25K
% of position
0.1%
9/13/2024
8.18M→8.17M
Common Stock
Indirect
Shares
−2K
Price / share
$6.06
Trade value
$12.12K
% of position
0.1%
9/13/2024
1.68M→1.68M
Common Stock
Indirect
Shares
−79.00
Price / share
$6.06
Trade value
$478.74
% of position
0.1%
9/13/2024
66.36K→66.28K
Total
Net shares
−266.34K
Net value
-$1.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/11/2024 | S · Sale | −214.56K | $6.60 | $1.42M | 2.6% | 8.39M | 8.18M |
| Common Stock Indirect | 9/11/2024 | S · Sale | −36.50K | $6.60 | $240.93K | 2.1% | 1.72M | 1.68M |
| Common Stock Indirect | 9/11/2024 | S · Sale | −1.44K | $6.60 | $9.50K | 2.1% | 67.80K | 66.36K |
| Common Stock Indirect | 9/13/2024 | S · Sale | −11.76K | $6.06 | $71.25K | 0.1% | 8.18M | 8.17M |
| Common Stock Indirect | 9/13/2024 | S · Sale | −2K | $6.06 | $12.12K | 0.1% | 1.68M | 1.68M |
| Common Stock Indirect | 9/13/2024 | S · Sale | −79.00 | $6.06 | $478.74 | 0.1% | 66.36K | 66.28K |
| Total | −266.34K | -$1.75M | ||||||
Derivative Transactions0
No derivative transactions reported